This article is from the K9 Magazine archives, subscribe to our newsletter & get our best dog news, tips and articles ---->The Food & Drug Administration approves new cancer drug for dogs: Whilst conducting medical trials, the drug called Palladia or toceranib phosphate, has been found to reduce cutaneous mast-cell tumours better than a placebo alternative.
These mast-cell tumours are responsible for one-in-five skin tumours found in dogs, which are often found as lumps on the skin but can be spread to other places. These are the second most common form of the 1.2 million cases of cancer reported each year in dogs.
Vets have been treating dogs for cancer for years but have mainly used chemotherapy drugs developed for humans and have never rigorously tested on dogs.
The Food & Drug Administration are out to prove Palladia’s effectiveness in canines and at the end of trials presented to the FDA 60% of dogs treated with the drug had their skin tumours shrink, disappear or stop growing.
These results were according to a news release from Pfizer Animal Health, the makers of Palladia.
The newspaper reports that the vice president of Pfizer Animal Health, George Fennell said that Palladia won’t be available in vets until 2010. He said that until then any dog owner’s should discuss treatments with their vet who may refer their dog to a specialist for treatment with Palladia.
Highly Recommended: As summer approaches, your dog will thank you for – clicking this link…!
Related posts:
- Canine Cancer Breakthrough: Could This Be First Effective Cancer Vaccination?
- Get Your Paws on Some Cool Prizes and Assist in the Battle Against Canine Cancer
- Breakthrough Vaccine To Help Dogs Suffering From Oral Canine Melanoma
- What You Need to Know About Canine Cancer
- Children Give Up Birthday Gifts in Battle Against Canine Cancer
